ResMed Inc.
Australian Securities ExchangeTotal Valuation
ResMed Inc. carries a market capitalization of 37.48B, placing it among publicly traded companies globally. Its enterprise value stands at 31.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 37.48B |
| Enterprise Value | 31.55B |
Share Statistics
ResMed Inc. currently has 145.04M shares outstanding.
| Shares Outstanding | 145.04M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
ResMed Inc. trades at a trailing price-to-earnings ratio of 21.30. The price-to-sales ratio is 5.85, and the price-to-book ratio stands at 4.65.
| PE Ratio | 21.30 |
| PS Ratio | 5.85 |
| PB Ratio | 4.65 |
| P/TBV Ratio | 10.71 |
| P/FCF Ratio | 15.89 |
| P/OCF Ratio | 17.13 |
Enterprise Valuation
On an enterprise value basis, ResMed Inc. trades at an EV/EBITDA multiple of 14.48 and an EV/FCF ratio of 15.44. The EV/Sales ratio of 5.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.47 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.70 |
| EV / EBITDA | 14.48 |
| EV / EBIT | 16.47 |
| EV / FCF | 15.44 |
Financial Position
ResMed Inc. maintains a current ratio of 3.01, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.01 |
| Quick Ratio | 2.00 |
| Debt / Equity | 12.99 |
| Debt / EBITDA | 0.39 |
| Interest Coverage | N/A |
Financial Efficiency
ResMed Inc. posts a return on equity of 23.86 and a return on invested capital of 21.91.
| Return on Equity (ROE) | 23.86 |
| Return on Assets (ROA) | 18.59 |
| Return on Invested Capital (ROIC) | 21.91 |
| Return on Capital Employed (ROCE) | 21.07 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.40 |
Taxes
Over the trailing twelve months, ResMed Inc. has paid 383.74M in income taxes, reflecting an effective tax rate of 20.16.
| Income Tax | 383.74M |
| Effective Tax Rate | 20.16 |
Stock Price Statistics
ResMed Inc.'s stock has declined approximately -31.87451% over the past 52 weeks. The 50-day moving average sits at 30.21, while the 200-day moving average is 36.26.
| Beta (5Y) | N/A |
| 52-Week Price Change | -31.87451% |
| 50-Day Moving Average | 30.21 |
| 200-Day Moving Average | 36.26 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, ResMed Inc. generated 5.54B in revenue and converted that into 1.52B in net income, yielding earnings per share of 1.04. EBITDA reached 2.18B, while operating income came in at 1.92B.
| Revenue | 5.54B |
| Gross Profit | 3.41B |
| Operating Income | 1.92B |
| Pretax Income | 1.90B |
| Net Income | 1.52B |
| EBITDA | 2.18B |
| EBIT | 1.92B |
| Earnings Per Share (EPS) | 1.04 |
Balance Sheet
ResMed Inc. holds 1.66B in cash and equivalents against 843.17M in total debt, resulting in a net debt position of -996.42M. Total book value stands at 6.96B, with working capital of 2.71B providing operational flexibility.
| Cash & Cash Equivalents | 1.66B |
| Total Debt | 843.17M |
| Net Debt | -996.42M |
| Equity (Book Value) | 6.96B |
| Book Value Per Share | 4.77 |
| Working Capital | 2.71B |
Cash Flow
ResMed Inc. produced 1.89B in operating cash flow over the past twelve months. After subtracting -153.70M in capital expenditures, free cash flow totaled 1.74B - equivalent to 1.19 per share.
| Operating Cash Flow | 1.89B |
| Capital Expenditures | -153.70M |
| Free Cash Flow | 1.74B |
| FCF Per Share | 1.19 |
Margins
ResMed Inc. operates with a gross margin of 61.59, reflecting its pricing power and cost economics. The operating margin of 34.60 and net profit margin of 27.44 provide insight into operational efficiency.
| Gross Margin | 61.59 |
| Operating Margin | 34.60 |
| Pretax Margin | 34.37 |
| Profit Margin | 27.44 |
| EBITDA Margin | 39.36 |
Dividends & Yields
The company's payout ratio of 22.39 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.23 |
| Dividend Yield | N/A |
| Payout Ratio | 22.39 |
| Shareholder Yield | 2.80 |
| FCF Yield | 6.29 |
Stock Splits
ResMed Inc.'s most recent stock split took place on August 12, 2010 with a 1:2 split ratio.
| Last Split Date | 8/12/2010 |
| Split Ratio | 1:2 |
Scores
ResMed Inc. posts an Altman Z-Score of 13.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 13.15 |